[New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D009921:Metaproterenol / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D013566:Sympathomimetics; D009921:Metaproterenol; D007545:Isoproterenol
Neiuwe beta-adrenoceptor stimulantia in de symptomatische behandeling van astma en chronisch obstruktief bronchiaallijden